Psych News Alert | Food and Drug Administration

Reviewing Significant FDA Psychiatry Approvals in 2025

12/29/25 11:00 AM

January The FDA approves the esketamine nasal spray Spravato as a monotherapy for adults with treatm...

Reviewing the FDA’s Major Psychiatry Approvals in 2024

12/27/24 12:00 AM

FDA Panel Votes 14-1 Against Clozapine REMS

11/20/24 12:00 AM

More Children Were Prescribed Low-Dose Antidepressants After FDA Warnings, Study Finds

6/24/24 11:16 AM

Following the Food and Drug Administration’s decision in 2004 to add a black-box warning to all anti...

FDA Approves Naloxone Nasal Spray for Over-the-Counter Sale

6/24/24 11:16 AM

Clinical Trial Supports Use of Brexpiprazole for Alzheimer's Agitation, Study Suggests

11/6/23 12:00 AM

FDA Approves Exxua for Treatment of Major Depression in Adults

10/2/23 12:00 AM

FDA Issues Draft Guidance for Conducting Clinical Trials With Psychedelic Substances

6/27/23 12:00 AM

FDA Approves Rexulti for Agitation Associated With Dementia Due to Alzheimer’s Disease

5/11/23 12:00 AM

The U.S. Food and Drug Administration (FDA) yesterday approved the expanded use of Rexulti (brexpipr...